Amgen Inc Stock Performance

AMGN Stock  USD 369.20  0.00  0.00%   
Amgen has a performance score of 6 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.78, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Amgen's returns are expected to increase less than the market. However, during the bear market, the loss of holding Amgen is expected to be smaller as well. Amgen Inc right now shows a risk of 1.94%. Please confirm Amgen Inc information ratio, downside variance, day typical price, as well as the relationship between the treynor ratio and kurtosis , to decide if Amgen Inc will be following its price patterns.

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Amgen Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain technical and fundamental indicators, Amgen may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more

Actual Historical Performance (%)

One Day Return
0.82
Five Day Return
(3.02)
Year To Date Return
12.68
Ten Year Return
150.89
All Time Return
107.3 K
Forward Dividend Yield
0.0262
Payout Ratio
0.4421
Last Split Factor
2:1
Forward Dividend Rate
9.66
Dividend Date
2026-03-06
 
Amgen dividend paid on 12th of December 2025
12/12/2025
1
J. Safra Sarasin Holding AG Has 69.74 Million Position in Amgen Inc. AMGN
01/27/2026
2
Dow closes above 50K for the first time in history
02/06/2026
3
Research Analysts Weekly Ratings Changes for Amgen
02/09/2026
4
The 5 Most Interesting Analyst Questions From Amgens Q4 Earnings Call
02/10/2026
5
Amgen is a Top-Ranked Momentum Stock Should You Buy
02/11/2026
6
Organon Q4 2025 Earnings Call Transcript
02/12/2026
7
AMGEN UPLIZNA
02/13/2026
Begin Period Cash Flow12 B
Total Cashflows From Investing Activities-1.9 B

Amgen Relative Risk vs. Return Landscape

If you would invest  33,920  in Amgen Inc on November 18, 2025 and sell it today you would earn a total of  2,999  from holding Amgen Inc or generate 8.84% return on investment over 90 days. Amgen Inc is currently generating 0.1573% in daily expected returns and assumes 1.9432% risk (volatility on return distribution) over the 90 days horizon. In different words, 17% of stocks are less volatile than Amgen, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Amgen is expected to generate 2.57 times more return on investment than the market. However, the company is 2.57 times more volatile than its market benchmark. It trades about 0.08 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.16 per unit of risk.

Amgen Target Price Odds to finish over Current Price

The tendency of Amgen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 369.20 90 days 369.20 
about 1.16
Based on a normal probability distribution, the odds of Amgen to move above the current price in 90 days from now is about 1.16 (This Amgen Inc probability density function shows the probability of Amgen Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Amgen has a beta of 0.78. This suggests as returns on the market go up, Amgen average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Amgen Inc will be expected to be much smaller as well. Additionally Amgen Inc has an alpha of 0.1826, implying that it can generate a 0.18 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Amgen Price Density   
       Price  

Predictive Modules for Amgen

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Amgen Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
365.17367.10406.11
Details
Intrinsic
Valuation
LowRealHigh
332.27381.87383.80
Details
32 Analysts
Consensus
LowTargetHigh
314.46345.56383.57
Details
Earnings
Estimates (0)
LowProjected EPSHigh
4.175.166.15
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Amgen. Your research has to be compared to or analyzed against Amgen's peers to derive any actionable benefits. When done correctly, Amgen's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Amgen Inc.

Amgen Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Amgen is not an exception. The market had few large corrections towards the Amgen's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Amgen Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Amgen within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.18
β
Beta against Dow Jones0.78
σ
Overall volatility
14.85
Ir
Information ratio 0.09

Amgen Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Amgen for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Amgen Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Amgen Inc has a poor financial position based on the latest SEC disclosures
Over 85.0% of the company shares are held by institutions such as insurance companies
Latest headline from prnewswire.com: AMGEN UPLIZNA

Amgen Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Amgen Stock often depends not only on the future outlook of the current and potential Amgen's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Amgen's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding542 M
Cash And Short Term Investments9.1 B

Amgen Fundamentals Growth

Amgen Stock prices reflect investors' perceptions of the future prospects and financial health of Amgen, and Amgen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Amgen Stock performance.

About Amgen Performance

By examining Amgen's fundamental ratios, stakeholders can obtain critical insights into Amgen's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Amgen is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 353.75  219.77 
Return On Tangible Assets 0.16  0.12 
Return On Capital Employed 0.23  0.21 
Return On Assets 0.09  0.12 
Return On Equity 0.89  0.94 

Things to note about Amgen Inc performance evaluation

Checking the ongoing alerts about Amgen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Amgen Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Amgen Inc has a poor financial position based on the latest SEC disclosures
Over 85.0% of the company shares are held by institutions such as insurance companies
Latest headline from prnewswire.com: AMGEN UPLIZNA
Evaluating Amgen's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Amgen's stock performance include:
  • Analyzing Amgen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Amgen's stock is overvalued or undervalued compared to its peers.
  • Examining Amgen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Amgen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Amgen's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Amgen's stock. These opinions can provide insight into Amgen's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Amgen's stock performance is not an exact science, and many factors can impact Amgen's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Will Biotechnology sector continue expanding? Could Amgen diversify its offerings? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Amgen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
1.116
Dividend Share
9.52
Earnings Share
14.21
Revenue Per Share
68.31
Quarterly Revenue Growth
0.086
Investors evaluate Amgen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Amgen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Amgen's market price to deviate significantly from intrinsic value.
Understanding that Amgen's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Amgen represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Amgen's market price signifies the transaction level at which participants voluntarily complete trades.